At Syndicate Bio, we lead precision medicine initiatives in diverse geographical regions starting from Africa, partnering with ecosystem stakeholders to ensure the benefits of scientific research accrue to all.
Our state-of-the-art labs enable advanced genomics research and analysis, including sequencing, tumor profiling, liquid biopsy, genomic profiling, and multi-omics data generation.
Our cutting-edge platforms enable patient recruitment, surveying, and engagement, enabling longitudinal data collection, recontacting studies, and clinical trial matching.
Our bioinformatics and analytics capabilities enable us to carry out target discovery and other precision medicine applications, facilitating data-driven insights and advancements.
We collaborate with patients, doctors, governments, academics, nonprofit and for-profit organizations, fostering partnerships that drive local precision medicine impact and accelerate innovation.
We build pre-competitive datasets and capabilities that accelerate innovation for humanity, fostering collaboration and sharing resulting benefits with primary communities.
We work as a co-innovator with stakeholders to translate and commercialize genomic datasets into drug targets, medicines, and other precision medicine applications.
At Syndicate Bio, we are dedicated to revolutionizing healthcare through precision medicine. Our focus is on personalized treatments, enhancing access to genetic testing, and connecting individuals with cutting-edge therapies for better health outcomes.
Learn More
